Breast Cancer Research

official impact factor 5.79

Open Access

BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families

Antonis C Antoniou*, Francine Durocher, Paula Smith, Jacques Simard, INHERIT BRCAs program members and Douglas F Easton

Breast Cancer Research 2006, 8:R3 doi:10.1186/bcr1365

Accesses  

  • Last 30 days: 46 accesses
  • Last year: 743 accesses
  • All time: 6541 accesses

Cited by

BioMed Central: 3 citations

Research article   Open Access Highly Accessed

Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: Risks of breast/ovarian cancer quoted should reflect the cancer burden in the family

D Gareth Evans, Andrew Shenton, Emma Woodward, Fiona Lalloo, Anthony Howell, Eamonn R Maher BMC Cancer 2008, 8:155 (30 May 2008)

Counselling about the risks of breast and ovarian cancer for women who carry a BRCA1 or BRCA2 mutation should take into account the family history, because these women have a higher risk of cancer than the average population risk indicates.

Research article   Open Access

Haplotype analysis of TP53 polymorphisms, Arg72Pro and Ins16, in BRCA1 and BRCA2 mutation carriers of French Canadian descent

Luca Cavallone, Suzanna L Arcand, Christine Maugard, Parviz Ghadirian, Anne-Marie Mes-Masson, Diane Provencher, Patricia N Tonin BMC Cancer 2008, 8:96 (10 April 2008)

Research article   Open Access

Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families

Francine Durocher, Yvan Labrie, Penny Soucy, Olga Sinilnikova, Damian Labuda, Paul Bessette, Jocelyne Chiquette, Rachel Laframboise, Jean Lépine, Bernard Lespérance, Geneviève Ouellette, Roxane Pichette, Marie Plante, Sean V Tavtigian, Jacques Simard BMC Cancer 2006, 6:230 (29 September 2006)